semaglutide brand name RYBELSUS® (semaglutide) tablets 7 mg or 14 mg List Price & Insurance Coverage Explained Switching from a compounded to

It is not intended to be a general entry strategy for GLP-1 therapy

Discover WHEN There's Hope on the Horizon The medications we supply are intended for patients with a body mass index (BMI) of 27 or higher, who have at least one weight-related condition, or for patients with a BMI of 30 or higher

14 percent said they had stopped taking the weight-loss meds because of the cost

(Lausanne) 9 , 672 (2018)

Weekly vs daily administration Efficacy comparison (20.9% vs 5-8%) Step therapy requirements Teen patient considerations Ozempic vs Mounjaro Diabetes Focus Both FDA-approved for diabetescompare off-label weight loss and coverage

Our Dallas medical weight loss program is designed to help patients transform their lives in a safe and comprehensive way so that they can both look and feel their best